RadNet director David Swartz sells $1.27 million in common stock

Published 12/03/2025, 02:34
RadNet director David Swartz sells $1.27 million in common stock

David Swartz, a director at RadNet , Inc. (NASDAQ:RDNT), a $3.65 billion medical diagnostic imaging services provider, sold 25,000 shares of the company’s common stock on March 7, according to a recent SEC filing. The stock, which InvestingPro analysis indicates is trading above its Fair Value, has declined nearly 30% year-to-date. The shares were sold at a weighted average price of $50.84, totaling approximately $1.27 million. Following this transaction, Swartz holds 174,067 shares directly, with an additional 37,019 shares held indirectly by his spouse. The shares were sold in multiple transactions, with prices ranging from $50.12 to $51.36. With a notably high P/E ratio of 1,290 and significant price volatility, investors seeking deeper insights into insider trading patterns and valuation metrics can access comprehensive analysis through InvestingPro’s detailed research reports.

In other recent news, RadNet released its fourth-quarter 2024 earnings report, showing a 13.5% increase in revenue to $477.1 million. However, the company’s earnings per share (EPS) of $0.07 fell short of the forecasted $0.20, missing expectations by 65%. Despite the revenue growth, RadNet’s stock experienced a decline following the announcement. The Digital Health segment saw significant growth, with revenues up by 28.1%, indicating strong performance in this area. Analysts from Raymond (NSE:RYMD) James upgraded RadNet’s stock rating to Strong Buy, citing an appealing valuation of its AI division, despite reducing the price target to $65 from $85. Meanwhile, Jefferies maintained a Buy rating on RadNet, although it adjusted the price target to $76 from $80, attributing the change to non-recurring issues like adverse weather conditions. RadNet’s management has projected Digital Health revenue to grow by 30% in 2025, with plans to expand its digital health infrastructure. The company’s substantial cash reserves, exceeding $700 million, position it well for future mergers and acquisitions.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.